Results 241 to 250 of about 161,796 (303)

Mechanistic basis of LolDF-mediated lipoprotein transport in Acinetobacter. [PDF]

Nat Commun
Pang J, Chen Y, Qiao W, Ju Z, Zhu X, Chang S, Wang L, Zhang Z, Zerang Z, Xu S, Chen Y, Li C, Ying B, Ding BS, Chen H, Zhang S, Wei X, Tang X, Dong H.   +18 more
europepmc   +1 more source

Evaluation of High-Density Lipoprotein Capacity to Acquire Free Cholesterol From Triglyceride-Rich Lipoproteins During Reverse Remnant-Cholesterol Transport in Familial Hypercholesterolemia. [PDF]

Endocrinol Diabetes Metab
Ganjali S, de Haan JB, Le Goff W, Kontush A, Sahebkar A.   +4 more
europepmc   +1 more source

Is the Commitment to LDL-C Eternal? [PDF]

Methodist Debakey Cardiovasc J
Sniderman AD.
europepmc   +1 more source

Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes. [PDF]

Diabetes Obes Metab
Ruotolo G, Harris C, Lin Y, Wilson JM, Pirro V, Duffin KL, Thomas MK, Hartman ML, Neill CO, Coskun T, Milicevic Z, Haupt A, Sattar N, Nicholls SJ.   +13 more
europepmc   +1 more source

Interaction between the number of KIV2 repeats and the cholesterol content of an Lp(a) particle: What to do with these novel data? [PDF]

J Lipid Res
Reyes-Soffer G, Ginsberg HN.
europepmc   +1 more source

Distinct Roles of Myeloid- and Hepatocyte-PLA2G6 Deletion in Mice With Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

Liver Int
Li G, Staffer S, Tuma-Kellner S, Merle U, Chamulitrat W.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lipoprotein Apheresis

Endocrinology and Metabolism Clinics of North America, 2015
Patients with familial hypercholesterolemia (FH) have early development of atherosclerosis and cardiovascular disease (CVD). Lipid level-lowering medications are not always successful in reducing increased low-density lipoprotein C (LDL-C) levels. Lipoprotein apheresis (LA) therapy has proven its clinical benefit in reducing CVD events for patients ...
Patrick M, Moriarty, Linda, Hemphill
openaire   +3 more sources

Lipoprotein (a)

Baillière's Clinical Endocrinology and Metabolism, 1995
Lipoprotein (a) is similar to low-density lipoprotein but is unique in having an additional apolipoprotein called apolipoprotein (a) (apo(a)) covalently linked to it. apo(a), which is a member of the plasminogen gene superfamily, has a protease domain which cannot be activated to cause fibrinolysis.
openaire   +2 more sources